| 1. |
Kelley BP, Patel SC, Marin HL, et al. Autoimmune encephalitis: pathophysiology and imaging review of an overlooked diagnosis. AJNR Am J Neuroradiol, 2017, 38(6): 1070-1078.
|
| 2. |
Dale RC, Merheb V, Pillai S, et al. Antibodies to surface dopamine-2 receptor in autoimmune movement and psychiatric disorders. Brain, 2012, 135(Pt 11): 3453-3468.
|
| 3. |
Scheffer IE, Berkovic S, Capovilla G, et al. ILAE classification of the epilepsies: Position paper of the ILAE Commission for Classification and Terminology. Epilepsia, 2017, 58(4): 512-521.
|
| 4. |
Yeshokumar AK, Pardo CA. Autoimmune epilepsies. Semin Pediatr Neurol, 2017, 24(3): 161-167.
|
| 5. |
Wright S, Lim M. Autoimmune epilepsy: the search for a definition. Dev Med Child Neurol, 2015, 57(5): 402-403.
|
| 6. |
Dubey D, Farzal Z, Hays R, et al. Evaluation of positive and negative predictors of seizure outcomes among patients with immune-mediated epilepsy: a meta-analysis. Ther Adv Neurol Disord, 2016, 9(5): 369-377.
|
| 7. |
柴曉洋, 王潔, 龐倩, 等. 自身免疫性腦炎相關性癲癇的研究進展. 中華神經醫學雜志, 2019, 18(2): 207-210.
|
| 8. |
Guerin J, Watson RE, Carr CM, et al. Autoimmune epilepsy: findings on MRI and FDG-PET. Br J Radiol, 2019, 92(1093): 20170869.
|
| 9. |
Baumgartner A, Rauer S, Mader I, et al. Cerebral FDG-PET and MRI findings in autoimmune limbic encephalitis: correlation with autoantibody types. J Neurol, 2013, 260(11): 2744-2753.
|
| 10. |
Baysal-Kirac L, Tuzun E, Altindag E, et al. Are there any specific EEG findings in autoimmune epilepsies? Clin EEG Neurosci, 2016, 47(3): 224-234.
|
| 11. |
Dubey D, Singh J, Britton JW, et al. Predictive models in the diagnosis and treatment of autoimmune epilepsy. Epilepsia, 2017, 58(7): 1181-1189.
|
| 12. |
Britton J. Autoimmune epilepsy. Handb Clin Neurol, 2016, 133: 219-245.
|
| 13. |
Cabezudo-García P, Mena-Vázquez N, Villagrán-García M, et al. Efficacy of antiepileptic drugs in autoimmune epilepsy: A systematic review. Seizure, 2018, 59: 72-76.
|
| 14. |
Byun JI, Lee ST, Jung KH, et al. Effect of immunotherapy on seizure outcome in patients with autoimmune encephalitis: A prospective observational registry study. PLoS One, 2016, 11(1): e0146455.
|
| 15. |
Bhatia S, Schmitt SE. Treating immune-related epilepsy. Curr Neurol Neurosci Rep, 2018, 18(3): 10.
|
| 16. |
Lancaster E. The diagnosis and treatment of autoimmune encephalitis. J Clin Neurol, 2016, 12(1): 1-13.
|
| 17. |
Missale C, Nash SR, Robinson SW, et al. Dopamine receptors: from structure to function. Physiol Rev, 1998, 78(1): 189-225.
|
| 18. |
Starr MS. The role of dopamine in epilepsy. Synapse, 1996, 22(2): 159-194.
|
| 19. |
al-Tajir G, Chandler CJ, Starr BS, et al. Opposite effects of stimulation of D1 and D2 dopamine receptors on the expression of motor seizures in mouse and rat. Neuropharmacology, 1990, 29(7): 657-661.
|
| 20. |
Bozzi Y, Borrelli E. Dopamine D2 receptor signaling controls neuronal cell death induced by muscarinic and glutamatergic drugs. Mol Cell Neurosci, 2002, 19(2): 263-271.
|
| 21. |
Vuong J, Devergnas A. The role of the basal ganglia in the control of seizure. J Neural Transm (Vienna), 2018, 125(3): 531-545.
|
| 22. |
Bozzi Y, Vallone D, Borrelli E. Neuroprotective role of dopamine against hippocampal cell death. J Neurosci, 2000, 20(22): 8643-8649.
|
| 23. |
Bozzi Y, Borrelli E. The role of dopamine signaling in epileptogenesis. Front Cell Neurosci, 2013, 7: 157.
|
